To Örebro University

Real-world data on the PI3Kd inhibitor idelalisib in relapsed/refractory CLL patients treated in Sweden 2020 (English)In: Leukemia and Lymphoma, ISSN 1042-8194, E-ISSN 1029-2403, Vol. 61, no Suppl. 1, p. 66-67Article in journal, Meeting abstract (Other academic) Published

Place, publisher, year, edition, pages

Taylor & Francis, 2020. Vol. 61, no Suppl. 1, p. 66-67

National Category

Cancer and Oncology

Identifiers

URN: urn:nbn:se:oru:diva-82429ISI: 000534385400049OAI: oai:DiVA.org:oru-82429DiVA, id: diva2:1435081

Conference

XVIII International Workshop on Chronic Lymphocytic Leukemia, Edinburgh, UK, September 20-23, 2019

Available from: 2020-06-04 Created: 2020-06-04 Last updated: 2020-06-04Bibliographically approved

Open Access in DiVA

No full text in DiVA

Authority records

Uggla, Bertil

Search in DiVA

By author/editor

Uggla, Bertil

By organisation

School of Medical Sciences

In the same journal

Leukemia and Lymphoma

On the subject

Cancer and Oncology

Search outside of DiVA

GoogleGoogle ScholarTotal: 145 hits